Medirom Regains Nasdaq Bid Price Compliance
Ticker: MRM · Form: 6-K · Filed: Jun 5, 2025 · CIK: 1819704
Sentiment: bullish
Topics: compliance, listing, nasdaq
TL;DR
Medirom's stock price is back above $1, keeping it on Nasdaq.
AI Summary
Medirom Healthcare Technologies Inc. announced on June 5, 2025, that it has regained compliance with Nasdaq's minimum bid price requirement. The company received a written notification from The Nasdaq Stock Market LLC on June 4, 2025, confirming this compliance.
Why It Matters
Regaining compliance with Nasdaq's minimum bid price requirement is crucial for Medirom to maintain its listing on the exchange, avoiding potential delisting and ensuring continued investor confidence.
Risk Assessment
Risk Level: low — The filing is a routine notification of compliance with exchange listing rules, indicating a positive resolution to a previous concern.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Registrant
- The Nasdaq Stock Market LLC (company) — Exchange regulator
- June 5, 2025 (date) — Press release date
- June 4, 2025 (date) — Notification date
FAQ
What specific Nasdaq listing rule did Medirom regain compliance with?
Medirom regained compliance with Nasdaq's minimum bid price requirement.
When did Medirom receive the notification from Nasdaq?
Medirom received the written notification on June 4, 2025.
What is the significance of regaining compliance with the minimum bid price requirement?
It allows Medirom to maintain its listing on The Nasdaq Stock Market LLC.
What form is this filing?
This filing is a Form 6-K, a report of a foreign private issuer.
What is the company's principal executive office address?
The company's principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 5, 2025 regarding Medirom Healthcare Technologies Inc. (MRM).